title: Prevention of endotoxin-induced acute lethality in Propionibacterium acnes-primed rabbits by an antibody to leukocyte integrin beta 2 with concomitant reduction of cytokine production.
abstract: Acute lethality was induced in rabbits by the sequential injection of Propionibacterium acnes and lipopolysaccharide (LPS). P. acnes induced the infiltration of inflammatory cells into the liver lobules during the early phase, and LPS in the late phase caused death in association with pathological changes mimicking hepatocellular necrosis or degeneration around infiltrated mononuclear cells and fibrin deposition in the liver, lung, and kidney, suggestive of a systemic Schwartzman-like reaction. These pathological changes were accompanied by the elevation of plasma tumor necrosis factor (TNF) and interleukin-8 (IL-8) levels. A neutralizing antibody to a leukocyte adhesion molecule, integrin beta 2 (CD18), administered at the time of LPS challenge, prevented reduced the elevation of plasma TNF and IL-8 levels. An anti-TNF alpha antibody but not an anti-IL-8 mediator in this model. These results indicate that CD18 is critically involved in vivo in activating leukocytes to produce cytokines in response to LPS.
authors.affiliation: Department of Pharmacology, School of Medicine, Kanazawa University, Kanazawa, Japan.
authors.forename: N
authors.initials: N
authors.lastname: Ikeda
authors.forename: N
authors.initials: N
authors.lastname: Mukaida
authors.forename: S
authors.initials: S
authors.lastname: Kaneko
authors.forename: N
authors.initials: N
authors.lastname: Fujioka
authors.forename: S
authors.initials: S
authors.lastname: Su
authors.forename: H
authors.initials: H
authors.lastname: Nariuchi
authors.forename: M
authors.initials: M
authors.lastname: Unoura
authors.forename: K
authors.initials: K
authors.lastname: Harada
authors.forename: Y
authors.initials: Y
authors.lastname: Nakanuma
authors.forename: K
authors.initials: K
authors.lastname: Kobayashi
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use; D018821:CD18 Antigens / Q000502:physiology*; D016207:Cytokines / Q000096:biosynthesis*; D006801:Humans; D016209:Interleukin-8 / Q000502:physiology; D008070:Lipopolysaccharides; D008297:Male; D051379:Mice; D011425:Propionibacterium acnes / Q000276:immunology / Q000472:pathogenicity*; D011817:Rabbits; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology
chemical_list: D000911:Antibodies, Monoclonal; D018821:CD18 Antigens; D016207:Cytokines; D016209:Interleukin-8; D008070:Lipopolysaccharides; D014409:Tumor Necrosis Factor-alpha